• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道中与疾病相关的微生物群落标志性物种。

Disease-associated microbiome signature species in the gut.

作者信息

Li Junhui, O'Toole Paul W

机构信息

APC Microbiome Ireland, University College Cork, Cork T12 K8AF, Ireland.

School of Microbiology, University College Cork, Cork T12 K8AF, Ireland.

出版信息

PNAS Nexus. 2024 Aug 21;3(9):pgae352. doi: 10.1093/pnasnexus/pgae352. eCollection 2024 Sep.

DOI:10.1093/pnasnexus/pgae352
PMID:39228810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11370893/
Abstract

There is an accumulation of evidence that the human gut microbiota plays a role in maintaining health, and that an altered gut microbiota (sometimes called ) associates with risk for many noncommunicable diseases. However, the dynamics of disease-linked bacteria in the gut and other body sites remain unclear. If microbiome alterations prove causative in particular diseases, therapeutic intervention may be possible. Furthermore, microbial signature taxa have been established for the diagnosis of some diseases like colon cancer. We identified 163 disease-enriched and 98 disease-depleted gut microbiome signature taxa at species-level resolution (signature species) from 10 meta-analyses of multiple diseases such as colorectal cancer, ulcerative colitis, Crohn's disease, irritable bowel syndrome, pancreatic cancer, and COVID-19 infection. Eight signature species were enriched and nine were depleted across at least half of the diseases studied. Compared with signature species depleted in diseases, a significantly higher proportion of disease-enriched signature species were identified as extra-intestinal (primarily oral) inhabitants, had been reported in bacteremia cases from the literature, and were aerotolerant anaerobes. These findings highlight the potential involvement of oral microbes, bacteremia isolates, and aerotolerant anaerobes in disease-associated gut microbiome alterations, and they have implications for patient care and disease management.

摘要

有越来越多的证据表明,人类肠道微生物群在维持健康方面发挥作用,而肠道微生物群的改变(有时称为肠道菌群失调)与许多非传染性疾病的风险相关。然而,肠道及其他身体部位与疾病相关细菌的动态变化仍不清楚。如果微生物群的改变被证明是某些特定疾病的病因,那么治疗干预可能是可行的。此外,已经建立了微生物特征分类群用于诊断某些疾病,如结肠癌。我们从10项关于多种疾病(如结直肠癌、溃疡性结肠炎、克罗恩病、肠易激综合征、胰腺癌和COVID-19感染)的荟萃分析中,在物种水平分辨率上(特征物种)确定了163种疾病富集和98种疾病耗竭的肠道微生物群特征分类群。在所研究的至少一半疾病中,有8个特征物种富集,9个特征物种耗竭。与疾病中耗竭的特征物种相比,疾病富集的特征物种中,有更高比例被确定为肠道外(主要是口腔)居民,在文献报道的菌血症病例中出现过,并且是耐氧厌氧菌。这些发现突出了口腔微生物、菌血症分离株和耐氧厌氧菌在与疾病相关的肠道微生物群改变中的潜在作用,对患者护理和疾病管理具有启示意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/11370893/030979972466/pgae352f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/11370893/030979972466/pgae352f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/11370893/030979972466/pgae352f1.jpg

相似文献

1
Disease-associated microbiome signature species in the gut.肠道中与疾病相关的微生物群落标志性物种。
PNAS Nexus. 2024 Aug 21;3(9):pgae352. doi: 10.1093/pnasnexus/pgae352. eCollection 2024 Sep.
2
Adjusting for age improves identification of gut microbiome alterations in multiple diseases.调整年龄可提高多种疾病中肠道微生物组改变的识别能力。
Elife. 2020 Mar 11;9:e50240. doi: 10.7554/eLife.50240.
3
Deciphering salivary microbiome signature in Crohn's disease patients with different factors contributing to dysbiosis.解析不同因素导致肠道菌群失调的克罗恩病患者的唾液微生物组特征。
Sci Rep. 2023 Nov 6;13(1):19198. doi: 10.1038/s41598-023-46714-8.
4
Metagenomic Analysis of Common Intestinal Diseases Reveals Relationships among Microbial Signatures and Powers Multidisease Diagnostic Models.常见肠道疾病的宏基因组分析揭示了微生物特征与多疾病诊断模型效能之间的关系。
mSystems. 2021 May 4;6(3):e00112-21. doi: 10.1128/mSystems.00112-21.
5
The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.口-肠轴:炎症性肠病患者的唾液和粪便微生物组失调。
Front Cell Infect Microbiol. 2022 Oct 7;12:1010853. doi: 10.3389/fcimb.2022.1010853. eCollection 2022.
6
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.炎症、营养供应和共生微生物群在肠道病原体感染中的作用。
Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014.
7
New insights into the interactions between the gut microbiota and the inflammatory response to ulcerative colitis in a mouse model of dextran sodium sulfate and possible mechanisms of action for treatment with PE&AFWE.深入了解肠道微生物群与葡聚糖硫酸钠诱导的小鼠溃疡性结肠炎炎症反应之间的相互作用,以及 PE&AFWE 治疗的可能作用机制。
Animal Model Exp Med. 2024 Apr;7(2):83-97. doi: 10.1002/ame2.12405. Epub 2024 Apr 25.
8
Overrepresentation of Enterobacteriaceae and is the major gut microbiome signature in Crohn's disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets.肠杆菌科和拟杆菌门过度表达是克罗恩病和溃疡性结肠炎的主要肠道微生物组特征;对 IBDMDB 数据集进行全面的宏基因组分析。
Front Cell Infect Microbiol. 2022 Oct 4;12:1015890. doi: 10.3389/fcimb.2022.1015890. eCollection 2022.
9
Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.健康与疾病中的肠道微生物群:双歧杆菌在肠道稳态中的作用。
World J Gastroenterol. 2014 Nov 7;20(41):15163-76. doi: 10.3748/wjg.v20.i41.15163.
10
Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease.系统评价:肠道微生物群及其在炎症性肠病中的潜在临床应用
Microorganisms. 2021 Apr 30;9(5):977. doi: 10.3390/microorganisms9050977.

引用本文的文献

1
From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease.从肠道菌群失调到肝脏炎症:关于脂肪性肝病中饮食-微生物群-肝脏轴的叙述性综述
Microorganisms. 2025 Jan 23;13(2):241. doi: 10.3390/microorganisms13020241.
2
Associations Between the Gut Microbiome, Inflammation, and Cardiovascular Profiles in People With Human Immunodeficiency Virus.人类免疫缺陷病毒感染者肠道微生物群、炎症与心血管特征之间的关联
J Infect Dis. 2025 Apr 15;231(4):e781-e791. doi: 10.1093/infdis/jiaf043.

本文引用的文献

1
Cross-Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment.跨队列肠微生物组特征与肠易激综合征表现和治疗相关。
Adv Sci (Weinh). 2024 Nov;11(41):e2308313. doi: 10.1002/advs.202308313. Epub 2024 Sep 7.
2
Gut dysbiosis: Ecological causes and causative effects on human disease.肠道菌群失调:生态原因及其对人类疾病的因果影响。
Proc Natl Acad Sci U S A. 2023 Dec 12;120(50):e2316579120. doi: 10.1073/pnas.2316579120. Epub 2023 Dec 4.
3
Microbiome-targeted interventions for the control of oral-gut dysbiosis and chronic systemic inflammation.
针对微生物群的干预措施,用于控制口腔-肠道生态失调和慢性全身性炎症。
Trends Mol Med. 2023 Nov;29(11):912-925. doi: 10.1016/j.molmed.2023.08.006. Epub 2023 Sep 18.
4
Robust cross-cohort gut microbiome associations with COVID-19 severity.与 COVID-19 严重程度相关的稳健跨队列肠道微生物组关联。
Gut Microbes. 2023 Jan-Dec;15(1):2242615. doi: 10.1080/19490976.2023.2242615.
5
Toward an improved definition of a healthy microbiome for healthy aging.迈向健康老龄化的健康微生物组定义的改进。
Nat Aging. 2022 Nov;2(11):1054-1069. doi: 10.1038/s43587-022-00306-9. Epub 2022 Nov 17.
6
Translating the Microbiome: What's the Target?微生物组的翻译:目标是什么?
Gastroenterology. 2023 Aug;165(2):317-319. doi: 10.1053/j.gastro.2023.04.008. Epub 2023 Apr 23.
7
No evidence for a common blood microbiome based on a population study of 9,770 healthy humans.没有证据表明存在基于 9770 名健康人群的通用血液微生物组。
Nat Microbiol. 2023 May;8(5):973-985. doi: 10.1038/s41564-023-01350-w. Epub 2023 Mar 30.
8
Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases.对 16S rRNA 微生物数据的荟萃分析确定了 COVID-19 患者在急性和恢复期肠道微生物群的变化。
BMC Microbiol. 2022 Nov 14;22(1):274. doi: 10.1186/s12866-022-02686-9.
9
Strain level and comprehensive microbiome analysis in inflammatory bowel disease multi-technology meta-analysis identifies key bacterial influencers of disease.炎症性肠病中的应变水平和综合微生物组分析 多技术荟萃分析确定了疾病的关键细菌影响因素。
Front Microbiol. 2022 Oct 14;13:961020. doi: 10.3389/fmicb.2022.961020. eCollection 2022.
10
The microbiome and gut homeostasis.微生物组与肠道内稳态。
Science. 2022 Jul;377(6601):eabp9960. doi: 10.1126/science.abp9960. Epub 2022 Jul 1.